Company's drug approved - New York

Yue Zhengjiang (at lectern), CEO of Aoxing Pharmaceutical Co Inc, announces that Aoxing has been granted licenses to produce a narcotic pain reliever in China from the China Food and Drug Administration, on Tuesday at the New York Stock Exchange. Hong Xiao / For China Daily